An anti-cancer medication is found potent to purge hidden virus in patients receiving HIV therapy, researchers at University of North Carolina in Orange County, North Carolina have claimed.
The researchers conducted a study in which it was discovered that anti-AIDS drugs fail to disengage reservoirs of HIV present in the immune system. For this reason, deadly HIV infection becomes active once a patient discontinues his medications. For complete cure of AIDS, flushing out HIV reservoirs is of crucial importance. The study was first published on July 25, 2012 in a scientific journal, Nature.
This analysis was collaboration between the Harvard School of Public Health, National Cancer Institute and the University of California. The tested drug was vorinostat that’s used to treat some kinds of lymphoma (cancer of the lymphatic system). The scientists undertook various experiments to assess how vorinostat activates the dormant HIV and the way it interrupts HIV storehouse.
Following a successful laboratory evaluation, vorinostat was given to eight HIV-infected guys, who were responding to the anti-AIDS treatment and their roused HIV levels were compared to their levels before anti-cancer medication.